首页> 外文期刊>Annals of Surgery >Does the Benefit of Sentinel Node Frozen Section Vary Between Patients With Invasive Duct, Invasive Lobular, and Favorable Histologic Subtypes of Breast Cancer?
【24h】

Does the Benefit of Sentinel Node Frozen Section Vary Between Patients With Invasive Duct, Invasive Lobular, and Favorable Histologic Subtypes of Breast Cancer?

机译:前哨淋巴结冷冻切片的益处在具有浸润性导管,浸润性小叶和良好组织学亚型的乳腺癌患者之间是否有所不同?

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND:: Although many questions regarding sentinel lymph node (SLN) biopsy in breast cancer have been answered by observational studies and, increasingly, by prospective trials, the role of intraoperative SLN assessment remains a matter of debate. Here we report in detail the results of intraoperative SLN assessment by frozen section (FS), with particular attention to variations in sensitivity and yield by histologic subtype, by tumor size, and by other clinicopathologic parameters. METHODS:: Five thousand two hundred ninety-eight consecutive patients with clinical stage T1-3N0 invasive breast carcinoma had SLN biopsy with intraoperative FS at Memorial Sloan Kettering Cancer Center between 1996 and 2004. We report the results of FS by sensitivity (the proportion of all positive SLN detected by FS) and by yield (the proportion of all FS procedures in which the FS was positive). RESULTS:: The sensitivity of FS was 61% overall, was higher for invasive duct (ID) than for invasive lobular (IL) cancers (62% vs. 52%; P = 0.006), and was marginally lower for favorable subtypes (46%; P = 0.26). The yield of FS was 21% overall, with no difference between ID and IL cancers (22% vs. 21%; P = 0.49), and with a substantially lower yield for favorable subtypes (3%; P < 0.001). The yield of FS increased with tumor size for ID and IL cancers (P < 0.001), but not for favorable subtypes. For both ID and IL cancers, the sensitivity and yield of FS were significantly higher with younger patient age, increasing tumor size, and lymphovascular invasion. The yield of FS was <10% for all patients with ID or IL tumors 50%, but the yield of FS is <10% for individuals >/=60 years of age with T1a/b tumors. Intraoperative FS may not be worthwhile for this low-yield subset, especially for patients with invasive breast cancer of favorable type.
机译:背景:尽管关于观察性淋巴结活检在乳腺癌中的许多问题已经通过观察性研究得到回答,并且越来越多地通过前瞻性试验得到了回答,但是术中SLN评估的作用仍是一个争论的问题。在这里,我们详细报告了通过冷冻切片(FS)进行术中SLN评估的结果,并特别注意了敏感性和产量的变化,包括组织学亚型,肿瘤大小和其他临床病理参数。方法:1996年至2004年间,Memorial Sloan Kettering癌症中心对549例临床分期为T1-3N0浸润性乳腺癌的患者进行了SLN活检,并术中进行了FS。我们通过敏感性报告FS的结果( FS检测到的所有阳性SLN)和产量(FS为阳性的所有FS程序的比例)。结果:FS的总体敏感性为61%,对于浸润性导管(ID)的敏感性高于浸润性小叶(IL)癌症(62%vs. 52%; P = 0.006),对于有利的亚型则略低(46) %; P = 0.26)。 FS的总产量为21%,ID和IL癌症之间无差异(22%比21%; P = 0.49),有利亚型的产量则低得多(3%; P <0.001)。对于ID和IL癌症,FS的产生随肿瘤大小的增加而增加(P <0.001),但对于有利的亚型则不然。对于ID和IL癌症,随着年龄的增长,肿瘤大小的增加和淋巴血管的侵袭,FS的敏感性和产率均显着更高。对于所有60岁以上的ID或IL肿瘤 50%,但对于年龄≥60岁且患有T1a / b肿瘤的个体,FS的产生率<10%。对于这种低产率的亚组,术中FS可能不值得,尤其对于患有浸润性乳腺癌的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号